title: Do indications to sublingual immunotherapy need to be revised?
authors.forename: Cristoforo
authors.initials: C
authors.lastname: Incorvaia
authors.forename: Marina
authors.initials: M
authors.lastname: Mauro
mesh_terms: D000286:Administration, Sublingual; D000293:Adolescent; D000485:Allergens / Q000008:administration & dosage / Q000009:adverse effects; D001249:Asthma / Q000628:therapy; D003888:Desensitization, Immunologic / Q000009:adverse effects* / Q000379:methods; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy
chemical_list: D000485:Allergens